These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18449490)

  • 1. Public consortium efforts in toxicogenomics.
    Mattes WB
    Methods Mol Biol; 2008; 460():221-38. PubMed ID: 18449490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of toxicogenomics to nonclinical drug development: regulatory science considerations.
    Sistare FD; Degeorge JJ
    Methods Mol Biol; 2008; 460():239-61. PubMed ID: 18449491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress.
    Williams-Devane CR; Wolf MA; Richard AM
    Toxicol Sci; 2009 Jun; 109(2):358-71. PubMed ID: 19332651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design issues in toxicogenomics using DNA microarray experiment.
    Lee KM; Kim JH; Kang D
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):200-8. PubMed ID: 16005921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of microarray assays for toxicogenomic and in vitro diagnostic applications.
    Thompson KL; Hackett J
    Methods Mol Biol; 2008; 460():45-68. PubMed ID: 18449482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of statistics in toxicogenomics.
    Elashoff M
    Methods Mol Biol; 2008; 460():69-87. PubMed ID: 18449483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public-Private Partnerships in the health sector: the Danish experience.
    Vrangbaek K
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):141-63. PubMed ID: 18634625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biomarkers Consortium: public and private sectors working in partnership to improve the public health.
    Zerhouni EA; Sanders CA; von Eschenbach AC
    Oncologist; 2007 Mar; 12(3):250-2. PubMed ID: 17405889
    [No Abstract]   [Full Text] [Related]  

  • 12. Integration of human biomonitoring exposure data into risk assessment: HESI initiatives and perspectives.
    Doerrer NG
    Int J Hyg Environ Health; 2007 May; 210(3-4):247-51. PubMed ID: 17321214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicogenomics--the research of environment and health at gene expression level].
    Dai Y; Zheng Y
    Wei Sheng Yan Jiu; 2003 Jul; 32(4):413-5. PubMed ID: 14535116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray probe mapping and annotation in cross-species comparative toxicogenomics.
    Calley JN; Mattes WB; Ryan TP
    Methods Mol Biol; 2008; 460():159-83. PubMed ID: 18449487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and future applications of microarrays in toxicological research.
    Gant TW
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):599-608. PubMed ID: 17696809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring and improving performance in multicenter research consortia.
    Greene SM; Hart G; Wagner EH
    J Natl Cancer Inst Monogr; 2005; (35):26-32. PubMed ID: 16287882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity.
    Mendrick DL
    Methods Mol Biol; 2008; 460():1-22. PubMed ID: 18449480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo predictive toxicogenomics.
    Porter MW
    Methods Mol Biol; 2008; 460():113-43. PubMed ID: 18449485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics in predictive toxicology.
    Storck T; von Brevern MC; Behrens CK; Scheel J; Bach A
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):90-7. PubMed ID: 11865677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.